1977
DOI: 10.1248/yakushi1947.97.4_359
|View full text |Cite
|
Sign up to set email alerts
|

Change of Alkaloid Composition and Acute Toxicity of Aconitum Roots during Processing

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
23
0

Year Published

1979
1979
2016
2016

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 66 publications
(23 citation statements)
references
References 0 publications
0
23
0
Order By: Relevance
“…It is thought that some of these efficacies depend on bushi diester alkaloid (BDA). However, BDA is highly toxic, and the LD 50 of raw Aconitum carmichaeli Debeaux for oral administration in mice was reported to be 1.61-5.49 g/kg [1]. Therefore, only processed aconite root is regulated in the 14th edition supplement of the Japanese Pharmacopoeia [2].…”
Section: Introductionmentioning
confidence: 99%
“…It is thought that some of these efficacies depend on bushi diester alkaloid (BDA). However, BDA is highly toxic, and the LD 50 of raw Aconitum carmichaeli Debeaux for oral administration in mice was reported to be 1.61-5.49 g/kg [1]. Therefore, only processed aconite root is regulated in the 14th edition supplement of the Japanese Pharmacopoeia [2].…”
Section: Introductionmentioning
confidence: 99%
“…The former is highly toxic because of its high content of DAs. Hikino et al [2] reported that LD50s to mice by oral administration of the raw tuberous root of A. carmichaeli are 1.61 g/kg (collected in Hokkaido, Japan) and 5.49 g/kg (collected in China), although the severity of toxicity in this type varies widely depending on the production region and the time of collection. Thus, prior to medicinal use, the tuberous root of Aconitum plants is generally processed by heating, immersing in salt (sodium chloride) solution, or coating with hydrated lime to attenuate the toxicity and control the medicinal effect.…”
Section: Introductionmentioning
confidence: 99%
“…In 1966, however, the monograph was deleted in the revised version of the JP7, probably because of this crude drug's ambiguous toxicity [10]. Then a variety of studies were performed on component characteristics and quality evaluation of both the raw and processed types of the crude drugs because of the medicinal importance of the tuberous root as a crude drug [2,[11][12][13][14][15][16][17][18][19][20]. Subsequently, in 2004, Processed Aconite Root (PAR) was newly adopted in Supplement II of the JP14, with strict control of the DAs by a purity test [21].…”
Section: Introductionmentioning
confidence: 99%
“…In order to evaluate the therapeutic effect of the crude drug, we have first examined the quality (the alkaloid content and composition as well as the toxicity) if some raw materials and their processed preparations, thereby clarifying the changes of these parameters during processing; processing of raw roots has been shown to cause hydrolysis of the highly poisonous constituents, the aconitines, to their deacetyl derivatives, the benzoylaconines, resulting in reduction of the acute toxicity of the roots (Hikino et al 1977). We have further investigated the pharmacological actions of some Aconitum roots (raw and processed) which are more directly related to their clinical efficacy and, in connection with them, have also examined in parallel those of the most famous principle, aconitine, and its analog benzoylaconine.…”
mentioning
confidence: 99%
“…In addition, the main congeners of the aconitine alkaloids in the Aconitum roots which are utilized in Japan are now known to be not aconitine but mesaconitine and hypaconitine (Hikino et al 1977). Thus, no systematic survey on the phar macological actions of these aconitine alkaloids with a sufficient purity has been performed.…”
mentioning
confidence: 99%